GlaxoSmithKline stock: buy or sell

GSK stock price: $39.50 -0.05% At close on Jul 28th, 2021

Updated on:
Jul 29th, 2021


GlaxoSmithKline stock brief

  • GlaxoSmithKline stock merely moved -0.05% to close at $39.50 on the stock market on Wednesday.
  • GlaxoSmithKline made public its earnings report on Wednesday

Should I buy GlaxoSmithKline stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $GSK stock a buy?

Currently, GlaxoSmithKline stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for $GSK in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell GlaxoSmithKline stock?

When you are a novel trader and you own stock shares with some profit, it's really hard to decide the good moment to sell and get your profits. Like when we have to buy shares, determining when is the best time to sell is not a fickle decision, and we must use our own trading style. Our trading system selects very simple setups to guide us on when is a good time to sell a stock. Be aware that these setups are not intended for shorting $GSK stock

As a rule of thumb, you must never keep a trading operation that results in greater losses than those expected by the time of the buy. When to sell shares always has to be ruled by the stop-loss (automatic or manual)

Is it time to sell GlaxoSmithKline stock?

In the current situation of GlaxoSmithKline there is not any eligible sell setup, so GlaxoSmithKline stock holders with operations in green can keep their positions

GlaxoSmithKline ratings

In the previous month we couldn't find any rating for GlaxoSmithKline

GlaxoSmithKline stock analysis

SMAs overview

GSK stock SMAs chart

Supports and resistances

The current resistance levels are:

  • R1: $39.87 (0.94% above)
  • R2: $40.05 (1.39% above)
  • R3: $40.11 (1.54% above)
  • The current support levels are:

  • S1: $39.44 (-0.15% below)
  • S2: $39.26 (-0.61% below)
  • S3: $39.03 (-1.19% below)
  • Bollinger bands

    The current distance between the upper and lower bands is less than 5%, and this means that price volatility is low. Reduced volatility is often the antecedent to a sudden movement (up or down), so we must be alert and manage our buy or sell orders accordingly

    GSK stock Bollinger Bands chart

    Relative strength index

    The RSI dropped below the overbought level of 70 in mid-June after just crossing to the overbough zone for a single day (weak signal). The RSI reading on Wednesday was 48.6. GlaxoSmithKline price dropped a 2.64% since RSI lost the overbought zone

    GSK stock RSI chart

    GlaxoSmithKline stock price history

    GlaxoSmithKline IPO was on Mar 28th, 1980 at $0.00 per share1. Since then, GSK stock has risen by -, with an average of 0.00% per year. If you had invested thousand dollars in GlaxoSmithKline stock at that time, it would worth $inf today.

    1: Adjusted price after possible price splits or reverse-splits

    GSK stock price history chart

    Price target for GlaxoSmithKline stock

    Nobody knows how much a stock will be priced in the future. However, many stock price forecasts are issued every day by banks, financial institutions and independent analysts.

    The following table shows the price predictions published by financial institutions in the last 30 days. Again, these estimates are not direct recommendations for small investors and must not be followed blindly.

    We don't have any target price posted in the previous 4 weeks for GlaxoSmithKline.

    Earnings and financials

    On Wednesday, GlaxoSmithKline ($GSK) had the earnings event and released the report.

    This compares to Earnings of $0.46 per share same quarter last year, so posted EPS means -100.00%. Looking at turnover, figures collapsed a -18.39% compared to $90.9B year over year.

    GlaxoSmithKline ($GSK) is hosting the earnings call.

    You must remember that the price action after the earnings release date usually has a higher volatility that may not respect your stop-loss orders.. You can probably find more information about the earnings call and the financial reports on the Investor Relations section of its website:

    GlaxoSmithKline performance

    GSK performance compared
    GlaxoSmithKline ($GSK) -1.20% 5.90% 6.70%

    Please read:
    The viewpoints expressed in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this article does not have any knowledge of the particular situations of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are expressed for education purposes only

    GlaxoSmithKline summary

    Wednesday, July 28th, 2021
    Day range$38.93 - $39.61
    Previous close$39.52
    Session gain-0.05%
    Average true range$0.54
    50d mov avg$39.54
    100d mov avg$37.99
    200d mov avg$36.70
    Earnings dateDecember 31st, 1969

    Frequently asked questions

    What is GlaxoSmithKline stock symbol?

    GlaxoSmithKline plc is a public company trading in the US stock market with the GSK symbol

    Is GlaxoSmithKline stock a buy or sell?

    GlaxoSmithKline had no ratings in the last 30 days Read the article to get additional tips on trading GSK stock.

    Will GSK go up?

    There were no price targets published by market analysts in the last month for GlaxoSmithKline.